Quality-of-life determinants in bronchogenic carcinoma patients candidates for curative surgery

N. Castejón, L. Hernández, S. Asensio, S. Bolufer, S. Romero (Alicante, Spain)

Source: Annual Congress 2006 - Innovative concepts in thoracic surgery
Session: Innovative concepts in thoracic surgery
Session type: Poster Discussion
Number: 865

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Castejón, L. Hernández, S. Asensio, S. Bolufer, S. Romero (Alicante, Spain). Quality-of-life determinants in bronchogenic carcinoma patients candidates for curative surgery. Eur Respir J 2006; 28: Suppl. 50, 865

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COPD and resectable bronchogenic carcinoma: worse quality of life after surgery?
Source: Eur Respir J 2006; 28: Suppl. 50, 717s
Year: 2006

Preoperative pulmonary complication risk assessment in patients undergoing curative surgery for lung cancer
Source: International Congress 2017 – Thoracic surgery
Year: 2017


Remediastinoscopy after neoadjuvant therapy for bronchogenic carcinoma
Source: Eur Respir J 2002; 20: Suppl. 38, 180s
Year: 2002

Surgical treatment of lung cancer after polyhemothetapy/radiotherapy down-staging in patients initially assessed as inoperable
Source: Eur Respir J 2006; 28: Suppl. 50, 718s
Year: 2006

Outcome after pneumonectomy in non small cell lung cancer patients receiving a neoadjuvant therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 478s
Year: 2004

Long-term follow-up comparing postoperative chemotherapy or radiotherapy and surgery with surgery alone in resectable nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2001; 18: Suppl. 33, 131s
Year: 2001

Surgical and survival outcomes of sleeve lobectomy after neoadjuvant theraphy in lung cancer: With group of 265 patients
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021

Possibilities of predicting cardiorespiratory complications in patients underwent pneumonectomy for non small-cell lung cancer (NSCLC)
Source: Eur Respir J 2002; 20: Suppl. 38, 463s
Year: 2002

Early complications after lung resections at patients treated for lung cancer with and without neoadjuvant hemiotheraphy
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011

Predictors of survival in patients undergoing radical surgery for malignant mesothelioma
Source: Eur Respir J 2002; 20: Suppl. 38, 187s
Year: 2002

Prognostic factors and surgical resection of pulmonary metastases from colorectal cancer
Source: International Congress 2019 – General thoracic surgery
Year: 2019

Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients?
Source: Eur Respir J 2002; 19: 464-468
Year: 2002



Surgical treatment for lung metastases in patients with colorectal cancer
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011


Combined and organ-saving operations in patients with advanced lung cancer after induction chemotherapy
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010

Salvage surgery in patients with locally advanced non-small cell lung cancer – outcomes and longtime results
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


Surgical treatment of spinal metastases in patients with lung carcinoma
Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery
Year: 2007


Preoperative evaluation for patients undergoing lung resection surgery
Source: Eur Respir J 2004; 24: Suppl. 48, 324s
Year: 2004

Laser recanalisation prior to radiotherapy is required in some patients with inoperable nonsmall cell pulmonary carcinoma
Source: Eur Respir J 2003; 22: Suppl. 45, 429s
Year: 2003

SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection
Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020
Year: 2020